Related Experiment Videos
Continuous arteriovenous hemofiltration in children.
1Division of Pediatric Nephrology, Mount Sinai School of Medicine, New York, NY 10029.
Pediatric Nephrology (Berlin, Germany)
|July 1, 1987
Summary
Continuous arteriovenous hemofiltration (CAVH) effectively reduced fluid overload in critically ill children, including neonates. While generally safe, patient outcomes depended on their severe underlying conditions.
Area of Science:
- Pediatric Critical Care Medicine
- Nephrology
- Extracorporeal Therapies
Background:
- Critically ill patients, particularly neonates, often experience fluid overload and electrolyte imbalances.
- Oligoanuria in critically ill children necessitates advanced fluid management strategies.
Purpose of the Study:
- To evaluate the safety and efficacy of Continuous Arteriovenous Hemofiltration (CAVH) in pediatric patients.
- To assess CAVH's utility in managing hypervolemia and electrolyte disturbances in neonates and older children.
Main Methods:
- CAVH utilized patient cardiac output for blood flow, requiring no external pumps.
- A variety of hemofilters were employed, enabling application in premature newborns and children.
- Treatment outcomes for 15 neonates and 8 older children were analyzed.
Main Results:
- All treated patients demonstrated a reduction in fluid overload.
- CAVH proved safe and effective, even in hemodynamically unstable pediatric patients.
- Four patients required adjunctive dialysis due to uremia management challenges.
Conclusions:
- CAVH is a viable extracorporeal treatment for fluid and electrolyte imbalances in critically ill children.
- The technique is applicable across a pediatric age range, including neonates.
- Patient survival was significantly influenced by the severity of their critical illness.